Published in Hypertension on April 04, 2005
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol (2010) 1.39
RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection. Clin Res Cardiol (2008) 1.34
Polytherapy with two or more antihypertensive drugs to lower blood pressure in elderly Ontarians. Room for improvement. Can J Cardiol (2007) 1.00
Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol (2008) 0.99
Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination. Vasc Health Risk Manag (2010) 0.87
Role of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension of chronic kidney disease and renoprotection. Study results. Hippokratia (2011) 0.86
Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat. Ther Adv Cardiovasc Dis (2009) 0.82
Educational paper: Progression in chronic kidney disease and prevention strategies. Eur J Pediatr (2012) 0.82
Perivascular adipose tissue as a regulator of vascular disease pathogenesis: identifying novel therapeutic targets. Br J Pharmacol (2016) 0.81
Characterization of the genomic structure and function of regions influencing renin and angiogenesis in the SS rat. Physiol Genomics (2011) 0.81
Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease. Chin Med J (Engl) (2016) 0.80
No HOPE without proof: do ARBs meet the standard for cardiovascular protection? Medscape J Med (2008) 0.79
Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence? Cardiovasc Diabetol (2013) 0.79
ACE inhibitors - angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease. Open Access Emerg Med (2010) 0.77
Need for quality improvement in renal systematic reviews. Clin J Am Soc Nephrol (2008) 0.76
Effects of Losartan-based therapy on the incidence of end-stage renal disease and associated costs in type 2 diabetes mellitus: A retrospective cost-effectiveness analysis in the United Kingdom. Curr Ther Res Clin Exp (2005) 0.76
Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs). Br J Clin Pharmacol (2011) 0.76
Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease. Clin J Am Soc Nephrol (2008) 0.76
Dynamic changes in the secondary structure of ECE-1 and XCE account for their different substrate specificities. BMC Bioinformatics (2012) 0.75
Severe hepatic encephalopathy in a patient with liver cirrhosis after administration of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy: a case report. J Med Case Rep (2010) 0.75
Living high training low induces physiological cardiac hypertrophy accompanied by down-regulation and redistribution of the renin-angiotensin system. Acta Pharmacol Sin (2013) 0.75
Aliskiren and valsartan combination therapy for the management of hypertension. Vasc Health Risk Manag (2010) 0.75
Drug combinations and all cause mortality in heart disease: dosages and types of ACE inhibitors need to be known. BMJ (2005) 0.75
Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection. Vasc Health Risk Manag (2010) 0.75
Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet (2006) 5.40
Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet (2011) 4.37
Importance of salt in determining blood pressure in children: meta-analysis of controlled trials. Hypertension (2006) 3.73
Salt intake is related to soft drink consumption in children and adolescents: a link to obesity? Hypertension (2008) 3.68
Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev (2005) 3.46
Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14
How far should salt intake be reduced? Hypertension (2003) 2.86
Reducing population salt intake worldwide: from evidence to implementation. Prog Cardiovasc Dis (2010) 2.64
Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension (2009) 2.29
Plasma sodium: ignored and underestimated. Hypertension (2004) 2.15
Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A (2007) 1.98
Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension (2005) 1.89
The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients. J Hypertens (2006) 1.63
Modest salt reduction lowers blood pressure in isolated systolic hypertension and combined hypertension. Hypertension (2005) 1.62
Salt intake of children and adolescents in South London: consumption levels and dietary sources. Hypertension (2014) 1.60
Plasma sodium and hypertension. Kidney Int (2004) 1.40
Urinary catecholamines and the relationship with blood pressure and pharmacological therapy. J Hypertens (2016) 1.39
Beneficial effects of potassium on human health. Physiol Plant (2008) 1.23
Altered dietary salt intake for preventing and treating diabetic kidney disease. Cochrane Database Syst Rev (2010) 1.22
Effects of potassium chloride and potassium bicarbonate on endothelial function, cardiovascular risk factors, and bone turnover in mild hypertensives. Hypertension (2010) 1.20
Surveys of the salt content in UK bread: progress made and further reductions possible. BMJ Open (2013) 1.14
Regional left ventricular deformation and geometry analysis provides insights in myocardial remodelling in mild to moderate hypertension. Eur J Echocardiogr (2007) 1.11
World Salt Awareness Week. J Clin Hypertens (Greenwich) (2011) 1.09
Dietary salt influences postprandial plasma sodium concentration and systolic blood pressure. Kidney Int (2011) 1.08
Salt: the dying echoes of the food industry. Am J Hypertens (2013) 1.08
Estimation of sodium excretion should be made as simple as possible, but not simpler: misleading papers and editorial on spot urines. J Hypertens (2015) 1.04
Reducing salt intake to prevent hypertension and cardiovascular disease. Rev Panam Salud Publica (2012) 1.02
Amiloride, a specific drug for hypertension in black people with T594M variant? Hypertension (2002) 1.00
Salt, blood pressure and the renin-angiotensin system. J Renin Angiotensin Aldosterone Syst (2003) 0.96
Salt, blood pressure and cardiovascular disease. Curr Opin Cardiol (2007) 0.94
Does reducing salt intake increase cardiovascular mortality? Kidney Int (2011) 0.93
Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives. Hypertension (2005) 0.93
Dietary sodium: a perspective on recent sodium evidence--its interpretation and controversies. J Clin Hypertens (Greenwich) (2013) 0.89
Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease. J Renin Angiotensin Aldosterone Syst (2006) 0.89
The epithelial sodium channel in hypertension: genetic heterogeneity and implications for treatment with amiloride. Am J Pharmacogenomics (2004) 0.89
Effect of modest salt reduction on skin capillary rarefaction in white, black, and Asian individuals with mild hypertension. Hypertension (2010) 0.87
Salt in food. Lancet (2005) 0.85
Blood pressure--importance of salt intake. Am J Hypertens (2005) 0.83
Proposed nomenclature for salt intake and for reductions in dietary salt. J Clin Hypertens (Greenwich) (2014) 0.82
Cardiovascular disease: salt and cardiovascular risk. Nat Rev Nephrol (2012) 0.82
Can a low-sodium, high-potassium salt substitute reduce blood pressure in rural Chinese people? Nat Clin Pract Cardiovasc Med (2008) 0.81
Salt and sugar: their effects on blood pressure. Pflugers Arch (2014) 0.81
Universal salt reduction. Hypertension (2004) 0.80
Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites. J Hypertens (2003) 0.80
Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension. J Renin Angiotensin Aldosterone Syst (2009) 0.79
Molecular variants of the sodium/hydrogen exchanger type 3 gene and essential hypertension. J Hypertens (2004) 0.78
Cross-Sectional Study of 24-Hour Urinary Electrolyte Excretion and Associated Health Outcomes in a Convenience Sample of Australian Primary Schoolchildren: The Salt and Other Nutrients in Children (SONIC) Study Protocol. JMIR Res Protoc (2015) 0.77
Altering plasma sodium concentration rapidly changes blood pressure during haemodialysis. Nephrol Dial Transplant (2013) 0.77
The frequent need for three or more drugs to treat essential hypertension. What evidence for optimal combinations? J Renin Angiotensin Aldosterone Syst (2002) 0.77
Long term effects of advice to reduce dietary salt. Front cover was highly misleading. BMJ (2003) 0.75
Salt intake and sympathetic activity. Circulation (2003) 0.75
Salt intake and cardiovascular disease. Nephrol Dial Transplant (2008) 0.75
Reducing population salt intake-time for global action. J Clin Hypertens (Greenwich) (2014) 0.75
World Action on Salt. Lancet (2008) 0.75
Salt and mortality. J Gen Intern Med (2008) 0.75
Salt: friend or foe? Lancet (2013) 0.75
Controversies in cardiology. Lancet (2006) 0.75
Salt intake and cardiovascular mortality. Am J Med (2007) 0.75
Estimating population salt intake in India using spot urine samples. J Hypertens (2017) 0.75
Urinary protein and essential hypertension in black and in white people. Hypertension (2002) 0.75
OS 03-04 INFLUENCE OF FAMILY AND PEER NETWORKS ON SALT REDUCTION IN CHILDREN IN THE SCHOOL-EDUSALT (SCHOOL BASED EDUCATION PROGRAMME TO REDUCE SALT) TRIAL. J Hypertens (2016) 0.75
Blood pressure in haemodialysis patients: the importance of the relationship between the renin-angiotensin-aldosterone system, salt intake and extracellular volume. J Renin Angiotensin Aldosterone Syst (2004) 0.75
OS 03-04 INFLUENCE OF FAMILY AND PEER NETWORKS ON SALT REDUCTION IN CHILDREN IN THE SCHOOL-EDUSALT (SCHOOL BASED EDUCATION PROGRAMME TO REDUCE SALT) TRIAL. J Hypertens (2016) 0.75
Plasma aldosterone: comparison of a new automated assay with a standard extraction method. Clin Chem (2006) 0.75